mercredi 30 août 2017

F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000

The Food and Drug Administration approved the first treatment that genetically alters a patient’s own cells to fight cancer. It will cost $475,000.

from NYT > Health http://ift.tt/2x6A3XH
via health&fitness

Aucun commentaire:

Enregistrer un commentaire